Browsing by Author Deedwania, Prakash

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2006Aggressive lipid lowering with atorvastatin reduces increased risk of cardiovascular events in patients with metabolic syndrome and coronary heart diseaseBarter, Philip; Carmena, Rafael; Deedwania, Prakash; Fruchart, Jean-Charles; Haffner, Steven; Shepherd, James; Treating to New Targets, (TNT) Investigators; Central Clinical School: Heart Research InstituteAggressive lipid lowering with atorvastatin reduces increased risk of cardiovascular events in patients with metabolic syndrome and coronary heart disease, European Heart Journal (English Edition), vol.27, Suppl 1,pp 931-932
2017Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trialKeech, Anthony (Tony); De Ferrari, Gaetano M; Deedwania, Prakash; et al, Various; Giugliano, Robert P; Gouni-Berthold, Ioanna; Kuder, J; Leiter, Lawrence A.; Murphy, Sabina A.; Sabatine, Marc S.; Wiviott, S; NH&MRC Clinical Trials CentreCardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial, The Lancet Diabetes & Endocrinology, vol.5, 12, 2017,pp 941-950
2008Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin TreatmentBarter, Philip; Boekholdt, S Matthijs; Cater, Nilo B; Deedwania, Prakash; DeMicco, David A; Gaffney, Michael; Grundy, Scott M; Holme, Ingar; Kastelein, John J.P.; LaRosa, John C.; Olsson, Anders G; Pedersen, Terje R; Szarek, Michael; van der Steeg, Wim A; Central Clinical School: Heart Research InstituteLipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment, Circulation, vol.117, 23, 2008,pp 3002-3009
2013A Novel Risk Classification Paradigm for Patients With Impaired Glucose Tolerance and High Cardiovascular RiskFulcher, Greg; Bethel, M. Angelyn; Califf, Robert M.; Chacra, Antonio R.; Deedwania, Prakash; et al, Various; Holman, Rury; Jenssen, Trond; Kahn, Steven; Levitt, Naomi; McMurray, John; Raptis, Sotirios; Northern Clinical School: MedicineA Novel Risk Classification Paradigm for Patients With Impaired Glucose Tolerance and High Cardiovascular Risk, The American Journal of Cardiology, vol.112, 2, 2013,pp 231-237
2017Updated risk factors should be used to predict development of diabetesFulcher, Greg; Bethel, Mary Angelyn; Boutati, Eleni; Chacra, Antonio R.; Deedwania, Prakash; Haffner, Steven; Holman, Rury; Hyland, K; Jenssen, Trond; Levitt, N; McMurray, John J. V.; Sun, Jie-Lena; Thomas, Laine; Northern Clinical School: MedicineUpdated risk factors should be used to predict development of diabetes, Journal of Diabetes and Its Complications, vol.31, 5, 2017,pp 859-863